Results per Page:
A triplet of drugs extends progression-free survival in advanced breast cancer
From the Breast Oncology Team, Clinical Research Division, and the VIKTORIA-1 study group
A COVID-19 Antiviral, Reconsidered: What modeling reveals about Molnupiravir
From the Schiffer Lab, Vaccine and Infectious Disease Division
A promising new antibody treatment for a neglected respiratory virus
From the Boonyaratanakornkit Lab, Vaccine and Infectious Disease Division
Space Invaders: Extracellular bacterial occupation alters tumor fate
From the Bullman Lab, Human Biology Division
A new high-throughput method for flu vaccine strain selection
From the Bloom Lab, Basic Sciences Division
More than nutrition: How breast milk IgG trains infant immunity
From the Koch Lab, Basic Sciences Division
Guiding the attack: CXCR3 leads CAR T cells to pediatric brain tumors
From the Vitanza Lab, Seattle Children’s Research Institute, University of Washington and the Cancer Consortium
From Data to Diagnosis: GREGoR aims to demystify rare diseases
From the Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium, including the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium
Rebuilding a stem cell incubator: a fetal liver co-culture fosters the rarest blood cells
From the Hadland Lab, Translational Science and Therapeutics Division
(TGF)Bait and Switch: Rewiring suppression into T cell power
From the Greenberg Lab, Translational Science and Therapeutics Division